1341 related articles for article (PubMed ID: 25441774)
1. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
2. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles as delivery carriers for anticancer prodrugs.
Fang JY; Al-Suwayeh SA
Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
[TBL] [Abstract][Full Text] [Related]
5. The application of prodrug-based nano-drug delivery strategy in cancer combination therapy.
Ge Y; Ma Y; Li L
Colloids Surf B Biointerfaces; 2016 Oct; 146():482-9. PubMed ID: 27400243
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy.
Sun B; Luo C; Cui W; Sun J; He Z
J Control Release; 2017 Oct; 264():145-159. PubMed ID: 28844757
[TBL] [Abstract][Full Text] [Related]
7. Lipid prodrug nanocarriers in cancer therapy.
Mura S; Bui DT; Couvreur P; Nicolas J
J Control Release; 2015 Jun; 208():25-41. PubMed ID: 25617724
[TBL] [Abstract][Full Text] [Related]
8. Dimeric prodrug-based nanomedicines for cancer therapy.
Li S; Shan X; Wang Y; Chen Q; Sun J; He Z; Sun B; Luo C
J Control Release; 2020 Oct; 326():510-522. PubMed ID: 32721523
[TBL] [Abstract][Full Text] [Related]
9. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
O'Hare A
Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
[TBL] [Abstract][Full Text] [Related]
10. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
[TBL] [Abstract][Full Text] [Related]
11. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
[TBL] [Abstract][Full Text] [Related]
12. [Polymer nanoparticles for the delivery of anticancer drug].
Nicolas J; Couvreur P
Med Sci (Paris); 2017 Jan; 33(1):11-17. PubMed ID: 28120750
[TBL] [Abstract][Full Text] [Related]
13. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
[TBL] [Abstract][Full Text] [Related]
15. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
16. "AND" logic gate regulated pH and reduction dual-responsive prodrug nanoparticles for efficient intracellular anticancer drug delivery.
Bai L; Wang XH; Song F; Wang XL; Wang YZ
Chem Commun (Camb); 2015 Jan; 51(1):93-6. PubMed ID: 25383506
[TBL] [Abstract][Full Text] [Related]
17. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Bhunchu S; Rojsitthisak P
Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
19. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
20. Self-assembly drug conjugates for anticancer treatment.
Fumagalli G; Marucci C; Christodoulou MS; Stella B; Dosio F; Passarella D
Drug Discov Today; 2016 Aug; 21(8):1321-9. PubMed ID: 27329268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
